Related Experiment Video
Updated: Jul 24, 2026
12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Association between contraceptive use and gestational diabetes: Missouri Pregnancy Risk Assessment Monitoring System,
Brittney A Kramer1, Jeremy Kintzel1, Venkata Garikapaty2
1Missouri Department of Health and Senior Services, Jefferson City, Missouri.
Preventing Chronic Disease
|July 18, 2014
Summary
Hormonal contraceptive use before pregnancy may increase the risk of gestational diabetes (GDM). Barrier methods, however, appear protective. Further research is needed to confirm these findings.
Area of Science:
- Reproductive Health
- Endocrinology
- Public Health
Background:
- The relationship between hormonal contraceptives and gestational diabetes (GDM) remains unclear.
- Investigating pre-pregnancy contraceptive use and GDM risk is crucial for maternal health.
- Previous studies have not definitively established a link between contraceptive type and GDM.
Purpose of the Study:
- To determine if pre-pregnancy contraceptive method influences maternal risk for gestational diabetes.
- To analyze the association between hormonal contraception and GDM incidence.
- To assess the impact of different contraceptive types on GDM development.
Main Methods:
- Analysis of data from the Missouri Pregnancy Risk Assessment Monitoring System (PRAMS) survey (2007-2008).
- Logistic regression modeling was employed to calculate adjusted odds ratios for GDM.
- Examined contraceptive use patterns in 2,741 women, with 8.3% diagnosed with GDM.
Main Results:
- Women using hormonal contraceptives showed increased odds of GDM (AOR = 1.43; 95% CI, 1.32-1.55).
- Hormonal contraceptive users had higher GDM risk compared to non-users.
- Barrier method users exhibited a protective effect against GDM (AOR = 0.79; 95% CI, 0.72-0.86).
Conclusions:
- Findings suggest a potential association between contraceptive method type and gestational diabetes risk.
- Contraception type may be a modifiable risk factor for GDM.
- Further investigation is warranted to validate contraception as a GDM risk factor.
Related Concept Videos
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:20Pathophysiology of Diabetes
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
01:26Oral Hypoglycemic Agents: Biguanides and Glitazones
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood glucose levels...
01:26Diabetes Mellitus: Introduction
Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
01:22Complications of Diabetes Mellitus
Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...